Blog

What is a Defective Product? A defective product is any product that is not safe for its intended use. This can include everything from a toy with small parts that pose a choking hazard to a car with faulty brakes. If a product is defective, it can cause serious injuries or even death. Who is Responsible…

products liability law is the body of law that governs the rights and obligations of parties in products liability cases. The law is designed to protect consumers from injuries caused by defective products and to hold producers and sellers responsible for damages caused by their products. products liability cases can be complex, and the…

If you have been injured by a defective product, you may be entitled to financial compensation. products liability law is designed to hold manufacturers and retailers responsible for injuries caused by their products. In a products liability claim, the plaintiff may be entitled to recover damages for personal injury or property damage caused by…

Losing a limb is one of the most horrific injuries an individual can endure. The physical, emotional, mental, and financial costs of amputations are devastating and severe. Amputations require hospitalization, extensive treatment, and potentially expensive prosthetics that may need to be replaced as time goes on. Amputations may be performed intentionally by medical professionals…

Necrotizing enterocolitis (NEC) is a serious gastrointestinal problem that mostly affects premature babies and that inflames and destroys intestinal tissue, causing necrosis. Severe NEC can cause a hole to form in a baby’s large or small intestine. Bacteria can leak through the hole into the abdomen or bloodstream, causing a potentially fatal infection and…

2012: The FDA approved Xeljanz for rheumatoid arthritis patients who were not responding to other available medications. 2017: The FDA approved Xeljanz as a treatment for psoriatic arthritis patients. 2018: The FDA approved Xeljanz as a treatment for ulcerative colitis patients. February 25, 2019: The FDA alerted the public to the Xeljanz safety clinical trial…